Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone for Irritability in Children and Adolescents with Autistic Disorder
NCT01624675Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of risperidone in Autism Spectrum Disorder (ASD), sponsored by Janssen Pharmaceutical. Started Sep 2012; status: completed.
02
Drugs
risperidone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01624675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01624675.